about
Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis.Linagliptin treatment improves cerebrovascular function and remodeling and restores reduced cerebral perfusion in Type 2 diabetes.Linagliptin reduces effects of ET-1 and TLR2-mediated cerebrovascular hyperreactivity in diabetes.Incretin manipulation in diabetes management.Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury.DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure.
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Linagliptin: from bench to bedside.
@en
type
label
Linagliptin: from bench to bedside.
@en
prefLabel
Linagliptin: from bench to bedside.
@en
P2860
P356
P1476
Linagliptin: from bench to bedside.
@en
P2093
John Doupis
P2860
P304
P356
10.2147/DDDT.S59523
P407
P577
2014-05-05T00:00:00Z